The presence of residual endogenous insulin secretion in patients with T1D has been linked to reduced risk for severe hypoglycemia (36, 37), development of diabetic retinopathy (38), promotion of statural growth in prepubertal children (39) and a sustained improvement in long-term glycemic control (7, 8). The gene discussed is INS; the disease is type 1 diabetes mellitus.